Journal of Shanghai Jiao Tong University (Medical Science) >
Effects of gingipain extract on the biological characteristics of oral squamous cell carcinoma cell HN6
Received date: 2023-09-20
Accepted date: 2023-12-26
Online published: 2024-02-28
Supported by
National Natural Science Foundation of China(82071112);Cross-disciplinary Research Fund of Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine(JYJC202005)
Objective ·To observe the effects of gingipain extract on the biological characteristics of oral squamous cell carcinoma cell HN6. Methods ·The HN6 cell line was selected, cultivated, and divided into different groups based on the protein concentration of gingipain extract from Porphyromonas gingivalis: control group, 3.125 μg/mL group, 6.25 μg/mL group, 12.5 μg/mL group, 25 μg/mL group, 50 μg/mL group, and 100 μg/mL group. After 24 and 48 h of cultivation, CCK-8 assay was used to detect the effects of gingipain extract on HN6 cell proliferation activity. Subsequent experiments were divided into control group, 25 μg/mL group and 50 μg/mL group. Flow cytometry was used to examine the effects of gingipain extract on cell cycle. Scratch assay and Transwell assay were performed to evaluate cell migration and invasion ability. Real-time PCR (RT-PCR) and Western blotting were used to measure the expression of E-cadherin and N-cadherin proteins and genes in cells. Results ·Stimulated with gingipain extract for 24 h, the HN6 cells showed significantly increased proliferation activity in the 25 μg/mL (P=0.025), 50 μg/mL (P=0.000), and 100 μg/mL (P=0.049) groups compared to the control group. After 48 h, proliferation activity was significantly higher in the 6.25 μg/mL(P=0.024), 12.5 μg/mL (P=0.006), 25 μg/mL (P=0.000), 50 μg/mL (P=0.000), and 100 μg/mL (P=0.000) groups compared to the control group. Cell cycle analysis revealed that, after 24 h of gingipain stimulation, the proportion of HN6 cells in the G1 phase decreased, while the proportion in the S+G2 phase significantly increased compared to the control group (25 μg/mL group: P=0.024; 50 μg/mL group: P=0.001). Compared to the control group, the scratch assay demonstrated a significant increase in the percentage of scratch closure as the concentration of gingipain extract increased (P=0.001). Compared to the control group, the Transwell invasion assay showed a significant increase in the number of cells passing through the bottom of the chamber as the concentration of gingipain extract increased. RT-PCR and Western blotting results indicated that as the concentration of gingipain extract increased, the expression levels of N-cadherin mRNA and protein in HN6 cells significantly increased, while the expression levels of E-cadherin mRNA and protein significantly decreased compared to the control group. Conclusion ·Gingipain extract could promote proliferation, migration, and invasion of oral squamous cell carcinoma HN6 cells.
Huxiao LI , Xiaotian LI , Xuri ZHAO , Huanyu ZHANG , Wei ZHOU , Zhongchen SONG . Effects of gingipain extract on the biological characteristics of oral squamous cell carcinoma cell HN6[J]. Journal of Shanghai Jiao Tong University (Medical Science), 2024 , 44(2) : 161 -168 . DOI: 10.3969/j.issn.1674-8115.2024.02.002
1 | KOMLóS G, CSURGAY K, HORVáTH F, et al. Periodontitis as a risk for oral cancer: a case-control study[J]. BMC Oral Health, 2021, 21(1): 640. |
2 | SANZ M, MARCO DEL CASTILLO A, JEPSEN S, et al. Periodontitis and cardiovascular diseases: consensus report[J]. J Clin Periodontol, 2020, 47(3): 268-288. |
3 | 王兴. 第四次全国口腔健康流行病学调查报告[M]. 北京: 人民卫生出版社, 2018. |
3 | WANG X. Report on the Fourth National Epidemiological Survey of Oral Health[M]. Beijing: People's Health Publishing House, 2018. |
4 | KAVARTHAPU A, GURUMOORTHY K. Linking chronic periodontitis and oral cancer: a review[J]. Oral Oncol, 2021, 121: 105375. |
5 | ALLON I, ABBA M, KAPLAN I, et al. Oral variant of acantholytic squamous cell carcinoma: histochemical and immunohistochemical features[J]. Acta Histochem, 2019, 121(8): 151443. |
6 | MORRISON A G, SARKAR S, UMAR S, et al. The contribution of the human oral microbiome to oral disease: a review[J]. Microorganisms, 2023, 11(2): 318. |
7 | LAMONT R J, FITZSIMONDS Z R, WANG H Z, et al. Role of Porphyromonas gingivalis in oral and orodigestive squamous cell carcinoma[J]. Periodontol 2000, 2022, 89(1): 154-165. |
8 | GENG F X, LIU J C, GUO Y, et al. Persistent exposure to Porphyromonas gingivalis promotes proliferative and invasion capabilities, and tumorigenic properties of human immortalized oral epithelial cells[J]. Front Cell Infect Microbiol, 2017, 7: 57. |
9 | KYLM? A K, SORSA T, JOUHI L, et al. Prognostic role of Porphyromonas gingivalis gingipain rgp and matrix metalloproteinase 9 in oropharyngeal squamous cell carcinoma[J]. Anticancer Res, 2022, 42(11): 5415-5430. |
10 | GUO K, LIU Y K, ZHOU H J, et al. Involvement of protein kinase C β-extracellular signal-regulating kinase 1/2/p38 mitogen-activated protein kinase-heat shock protein 27 activation in hepatocellular carcinoma cell motility and invasion[J]. Cancer Sci, 2008, 99(3): 486-496. |
11 | 张桓瑜, 江旖婷, 朱晓晨, 等. 牙龈素提取物对小鼠脑神经炎症的影响[J]. 上海交通大学学报(医学版), 2022, 42(5): 570-577. |
11 | ZHANG H Y, JIANG Y T, ZHU X C, et al. Effects of gingipain extracts on brain neuroinflammation in mice[J]. Journal of Shanghai Jiao Tong University (Medical Science), 2022, 42(5): 570-577. |
12 | KOLIARAKIS I, MESSARITAKIS I, NIKOLOUZAKIS T K, et al. Oral bacteria and intestinal dysbiosis in colorectal cancer[J]. Int J Mol Sci, 2019, 20(17): 4146. |
13 | MALINOWSKI B, W?SIERSKA A, ZALEWSKA K, et al. The role of Tannerella forsythia and Porphyromonas gingivalis in pathogenesis of esophageal cancer[J]. Infect Agent Cancer, 2019, 14: 3. |
14 | TAN Q, MA X, YANG B, et al. Periodontitis pathogen Porphyromonas gingivalis promotes pancreatic tumorigenesis via neutrophil elastase from tumor-associated neutrophils[J]. Gut Microbes, 2022, 14(1): 2073785. |
15 | GAO S G, LI S G, MA Z K, et al. Presence of Porphyromonas gingivalis in esophagus and its association with the clinicopathological characteristics and survival in patients with esophageal cancer[J]. Infect Agent Cancer, 2016, 11: 3. |
16 | LIU Y W, YUAN X, CHEN K S, et al. Clinical significance and prognostic value of Porphyromonas gingivalis infection in lung cancer[J]. Transl Oncol, 2021, 14(1): 100972. |
17 | CHANG C R, WANG H Y, LIU J C, et al. Porphyromonas gingivalis infection promoted the proliferation of oral squamous cell carcinoma cells through the miR-21/PDCD4/AP-1 negative signaling pathway[J]. ACS Infect Dis, 2019, 5(8): 1336-1347. |
18 | WOO B H, KIM D J, CHOI J I, et al. Oral cancer cells sustainedly infected with Porphyromonas gingivalis exhibit resistance to Taxol and have higher metastatic potential[J]. Oncotarget, 2017, 8(29): 46981-46992. |
19 | LIU S Y, ZHOU X D, PENG X, et al. Porphyromonas gingivalis promotes immunoevasion of oral cancer by protecting cancer from macrophage attack[J]. J Immunol, 2020, 205(1): 282-289. |
20 | INABA H, SUGITA H, KUBONIWA M, et al. Porphyromonas gingivalis promotes invasion of oral squamous cell carcinoma through induction of proMMP9 and its activation[J]. Cell Microbiol, 2014, 16(1): 131-145. |
21 | OHSHIMA J, WANG Q, FITZSIMONDS Z R, et al. Streptococcus gordonii programs epithelial cells to resist ZEB2 induction by Porphyromonas gingivalis[J]. Proc Natl Acad Sci USA, 2019, 116(17): 8544-8553. |
22 | REN J L, HAN X, LOHNER H, et al. P. gingivalis infection upregulates PD-L1 expression on dendritic cells, suppresses CD8+ T-cell responses, and aggravates oral cancer[J]. Cancer Immunol Res, 2023, 11(3): 290-305. |
23 | WHEELOCK M J, JOHNSON K R. Cadherins as modulators of cellular phenotype[J]. Annu Rev Cell Dev Biol, 2003, 19: 207-235. |
24 | CHRISTOFORI G. Changing neighbours, changing behaviour: cell adhesion molecule-mediated signalling during tumour progression[J]. EMBO J, 2003, 22(10): 2318-2323. |
25 | LAMOUILLE S, XU J, DERYNCK R. Molecular mechanisms of epithelial-mesenchymal transition[J]. Nat Rev Mol Cell Biol, 2014, 15(3): 178-196. |
26 | XU Z L, CHEN Z M, PENG M S, et al. MicroRNA miR-490-5p suppresses pancreatic cancer through regulating epithelial-mesenchymal transition via targeting MAGI2 antisense RNA 3[J]. Bioengineered, 2022, 13(2): 2673-2685. |
27 | PIERCEALL W E, WOODARD A S, MORROW J S, et al. Frequent alterations in E-cadherin and α- and β-catenin expression in human breast cancer cell lines[J]. Oncogene, 1995, 11(7): 1319-1326. |
28 | DERYCKE L D M, BRACKE M E. N-cadherin in the spotlight of cell-cell adhesion, differentiation, embryogenesis, invasion and signalling[J]. Int J Dev Biol, 2004, 48(5/6): 463-476. |
29 | GRABOWSKA M M, DAY M L. Soluble E-cadherin: more than a symptom of disease[J]. Front Biosci (Landmark Ed), 2012, 17(5): 1948-1964. |
30 | KATZ J, YANG Q B, ZHANG P, et al. Hydrolysis of epithelial junctional proteins by Porphyromonas gingivalis gingipains[J]. Infect Immun, 2002, 70(5): 2512-2518. |
/
〈 |
|
〉 |